NCT06730711 Association Between Blood Pressure and Risk of PSCI
| NCT ID | NCT06730711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital of Chongqing Medical University |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2024-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2024-09-01 with a primary completion date of 2024-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective cohort study was designed to explore the relationship between blood pressure and cognitive impairment after stroke
Eligibility Criteria
Inclusion criteria: 1. Patient diagnosed with stroke by CT or MRI, 2. Patients completed the MMSE scale at least once during hospitalization 3. The follow-up time was more than three months after the stroke occurred; Exclusion criteria: 1. Patients with incomplete data, follow-up time less than three months after the stroke occurred less than 3 months, 2. Patients with pre-existing cognitive impairment before stroke according to their medical records, 3. patients failed to complete MMSE assessment because of aphasia or any other reasons, 4. Patients combined with malignant tumors, patients combined with psychiatric disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06730711 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06730711 currently recruiting?
Yes, NCT06730711 is actively recruiting participants. Contact the research team at baidingqun@hospital.cqmu.edu.cn for enrollment information.
Where is the NCT06730711 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT06730711 clinical trial?
NCT06730711 is sponsored by First Affiliated Hospital of Chongqing Medical University. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.